FDA Approves Ovarian Cancer Treatment Based on New Biomarker
On Wednesday, the U.S. Food and Drug Administration (FDA) expanded the use of the molecularly targeted therapeutic niraparib (Zejula)...
Tag: gynecologic cancer
On Wednesday, the U.S. Food and Drug Administration (FDA) expanded the use of the molecularly targeted therapeutic niraparib (Zejula)...
“We are in a promising time for cancer research and treatment; however, ovarian cancer remains difficult to treat, since...